000 01592 a2200481 4500
005 20250517104939.0
264 0 _c20170620
008 201706s 0 0 eng d
022 _a1470-8728
024 7 _a10.1042/BCJ20160476
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNaylor, Jacqueline
245 0 0 _aUse of CRISPR/Cas9-engineered INS-1 pancreatic β cells to define the pharmacology of dual GIPR/GLP-1R agonists.
_h[electronic resource]
260 _bThe Biochemical journal
_c09 2016
300 _a2881-91 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCell Line
650 0 4 _aClustered Regularly Interspaced Short Palindromic Repeats
650 0 4 _aGlucagon-Like Peptide 1
_xagonists
650 0 4 _aGlucose
_xpharmacology
650 0 4 _aGlucose Tolerance Test
650 0 4 _aHumans
650 0 4 _aInsulin
_xmetabolism
650 0 4 _aInsulin Secretion
650 0 4 _aIslets of Langerhans
_xcytology
650 0 4 _aKaryotyping
650 0 4 _aMice
650 0 4 _aMice, Knockout
650 0 4 _aReceptors, Gastrointestinal Hormone
_xagonists
700 1 _aSuckow, Arthur T
700 1 _aSeth, Asha
700 1 _aBaker, David J
700 1 _aSermadiras, Isabelle
700 1 _aRavn, Peter
700 1 _aHowes, Rob
700 1 _aLi, Jianliang
700 1 _aSnaith, Mike R
700 1 _aCoghlan, Matthew P
700 1 _aHornigold, David C
773 0 _tThe Biochemical journal
_gvol. 473
_gno. 18
_gp. 2881-91
856 4 0 _uhttps://doi.org/10.1042/BCJ20160476
_zAvailable from publisher's website
999 _c26233085
_d26233085